InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Van Voorhees Seth. Insider active across 2 companies, notably PDS Biotechnology Corp. Aggregated, 4 filings have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €173k. Activity tracked since 15 June 2021. The latest transaction was filed on 16 December 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Van Voorhees Seth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
30,000 shares@ US$1.1062.3% of flowCommon Stock, par value $0.001 per shareSEC:0001415889-22-012652:0
Canonical exit: 16 Mar 2023 (T+90)
8,716 shares@ US$1.1218.8% of flowCommon Stock, par value $0.001 per shareSEC:0001415889-22-012650:0
Canonical exit: 23 Feb 2023 (T+90)
8,716 shares@ US$1.1218.8% of flowCommon Stock, par value $0.001 per shareSEC:0001415889-22-011778:0
Canonical exit: 23 Feb 2023 (T+90)
17,647 shares@ US$8.50100.0% of flowCommon StockSEC:0001140361-21-021491:0
Canonical exit: 13 Sept 2021 (T+90)
4 of 4 declarations
About Van Voorhees Seth
VAN VOORHEES SETH is a declarant linked to NRX Pharmaceuticals, Inc. and PDS Biotechnology Corp, where he holds the role of Chief Financial Officer. The total number of filings is 5. In the sampled recent filings, all transactions are acquisitions, with buy volume of EUR 297151, no sales, and a date range from 2021-06-17 to 2022-12-19.
